Plasma Exchange in the Setting of Immune-Mediated Multiple Organ Failure in the Cardiac ICU During ECMO: A Case

Sonia Labarinas1, Kalpana Norbisrath1, Ibeh Nnaemeka2

  • 1Children's Heart Institute, Pediatric Cardiac Critical Care, Advanced Cardiopulmonary Therapies and Transplantation, University of Texas-Health Science Center at Houston, Houston, Texas, USA.

PubMed

Insights

Therapeutic plasma exchange (TPE) may improve platelet counts in critically ill children with thrombocytopenia-associated multiple organ failure (TAMOF) on extracorporeal membrane oxygenation (ECMO). This study found TPE reduced organ severity scores but noted a high mortality rate.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiovascular Surgery
  • Hematology

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for pediatric cardio-respiratory failure.
  • Thrombocytopenia-associated multiple organ failure (TAMOF) is a severe complication in children on ECMO.
  • Therapeutic plasma exchange (TPE) is a potential treatment for TAMOF.

Purpose of the Study:

  • To describe the use and outcomes of TPE in critically ill children with TAMOF undergoing ECMO.
  • To evaluate the impact of TPE on platelet counts and organ severity scores in this patient population.

Main Methods:

  • A single-center retrospective case series of seven pediatric patients with congenital cardiac disease on ECMO and diagnosed with TAMOF.
  • Patients received TPE using a centrifugation-based apheresis instrument with bivalirudin for anticoagulation.
  • Data collected included patient demographics, ECMO characteristics, TPE details, platelet counts, and organ severity scores.

Main Results:

  • Seven patients underwent 30 TPE sessions; median sessions per patient was 3.
  • Median platelet count increased significantly post-TPE (45 to 64 × 10^9/L, p < 0.001) without transfusions.
  • Modified organ severity index decreased significantly (13 to 12, p < 0.001).
  • The overall mortality rate was 71%.

Conclusions:

  • Therapeutic plasma exchange may be effective in improving platelet counts in pediatric TAMOF patients on ECMO.
  • TPE demonstrated a reduction in organ severity scores in this cohort.
  • Despite potential benefits, the high mortality rate highlights the severity of TAMOF in ECMO patients.

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
188
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
320
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468